Want to see IN:IOLCP full AI Analyst Report?
IOLCP Stock Chart & Stats
₹84.09
-₹4.90(-1.13%)
At close: 4:00 PM EST
₹84.09
-₹4.90(-1.13%)
Day’s Range― - ―
52-Week Range₹67.14 - ₹179.65
Previous CloseN/A
Volume410.76K
Average Volume (3M)113.78K
Market Cap
₹42.36B
Enterprise Value₹29.95K
Total Cash (Recent Filing)₹2.02B
Total Debt (Recent Filing)₹1.35B
Price to Earnings (P/E)31.2
Beta1.52
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.69%
Share Statistics
EPS (TTM)4.69
Shares Outstanding293,527,500
10 Day Avg. Volume248,884
30 Day Avg. Volume113,785
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)1.19
Price to Sales (P/S)0.92
P/FCF Ratio55.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.7
Revenue Forecast (FY)₹26.48B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageSustained low leverage and a materially larger equity base provide financial flexibility through cycles. This durable strength supports capex, regulatory spend and working capital needs in chemicals and APIs, reducing refinancing risk and enabling strategic investments over the next several months.
Diversified Manufacturing Across APIs And ChemicalsA dual focus on pharmaceutical APIs and chlor‑alkali/specialty chemicals diversifies revenue streams and end markets. This structural mix lowers dependency on a single cycle, lets the company allocate capacity to higher‑margin products, and preserves cash flow resilience over 2–6 months.
Recent Revenue Rebound And Strong EPS GrowthA rebound in top-line and strong reported EPS growth indicate improving demand and better capacity utilization. If sustained, this trend can translate into steadier operating leverage and support medium‑term margin recovery and cash generation versus recent years of stagnation.
Bears Say
Material Margin Compression Since FY2021A structural drop in gross and net margins versus prior peaks signals lasting pressure from pricing, mix, or higher input costs. Reduced margin levels constrain reinvestment, lower operating returns and make achieving prior ROE more difficult absent sustained product‑mix or pricing improvement.
Volatile And Weak Free Cash Flow ConversionInconsistent free cash flow and weak conversion of earnings to cash reduce the company's ability to fund capex, pay dividends, or pursue M&A from internal sources. Over the medium term this increases reliance on external financing and limits strategic optionality in a cyclical industry.
Normalized, Lower Return On EquityA marked decline in ROE indicates the business now generates much lower returns on invested capital. Persistently lower ROE can signal structural profitability issues or suboptimal capital allocation and will pressure shareholder returns unless margins or growth sustainably improve.
IOL Chemicals & Pharmaceuticals Ltd. News
IOLCP FAQ
What was IOL Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
IOL Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹67.14 and its highest was ₹179.65 in the past 12 months.
What is IOL Chemicals & Pharmaceuticals Ltd.’s market cap?
IOL Chemicals & Pharmaceuticals Ltd.’s market cap is ₹42.36B.
When is IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 6 days.
How were IOL Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
IOL Chemicals & Pharmaceuticals Ltd. released its earnings results on May 20, 2026. The company reported ₹1.8 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.8.
Is IOL Chemicals & Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts IOL Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued.
Does IOL Chemicals & Pharmaceuticals Ltd. pay dividends?
IOL Chemicals & Pharmaceuticals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.69%. See more information on IOL Chemicals & Pharmaceuticals Ltd. dividends here
What is IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IOL Chemicals & Pharmaceuticals Ltd. have?
IOL Chemicals & Pharmaceuticals Ltd. has 293,527,500 shares outstanding.
What happened to IOL Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
IOL Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹1.8 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 8.466%.
Which hedge fund is a major shareholder of IOL Chemicals & Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:IOLCP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IOL Chemicals & Pharmaceuticals Ltd.
Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.
Technical Analysis
Aarti Drugs Limited
―
Granules India Limited
―
Hikal Limited
―
Neuland Laboratories Ltd.
―
Solara Active Pharma Sciences Ltd.
―